These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15255470)

  • 21. Thyroid hemorrhage after thrombolytic therapy for acute myocardial infarction.
    Chia PL
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):935-6. PubMed ID: 18695434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemothorax and an abdominal hematoma after treatment of ischemic cardiomyopathy with warfarin.
    Kollef MH; Gronski TJ
    Heart Lung; 1994; 23(2):125-7. PubMed ID: 8206769
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute iritis and transient renal impairment following thrombolytic therapy for acute myocardial infarction.
    Birnbaum Y; Barash D; Rechavia E; Regev A; Stahl B; Mager A
    Ann Pharmacother; 1993 Dec; 27(12):1539-40. PubMed ID: 8305792
    [No Abstract]   [Full Text] [Related]  

  • 24. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
    Barsam A; Heatley CJ; Herbert L
    Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alveolar haemorrhage associated with the primary antiphospholipid syndrome].
    Dabar G; Harmouch C
    Rev Mal Respir; 2013 Jan; 30(1):71-6. PubMed ID: 23318193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tamponade without cardiac rupture after repetitive thrombolysis in acute myocardial infarction].
    Georges JL; Tabone X; Metzger JP; Tamisier D; Baubion N; Vacheron A
    Arch Mal Coeur Vaiss; 1992 Sep; 85(9):1343-6. PubMed ID: 1290398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolytic therapy and cocaine-associated acute myocardial infarction.
    Boniface KS; Feldman JA
    Am J Emerg Med; 2000 Sep; 18(5):612-5. PubMed ID: 10999580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol embolism: a fatal complication after thrombolytic therapy for acute myocardial infarction.
    Rivera-Manrique E; Castro-Salomó A; Azón-Masoliver A; Marin LM
    Arch Intern Med; 1998 Jul; 158(14):1575. PubMed ID: 9679800
    [No Abstract]   [Full Text] [Related]  

  • 29. CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction.
    Uglietta JP; O'Connor CM; Boyko OB; Aldrich H; Massey EW; Heinz ER
    Radiology; 1991 Nov; 181(2):555-9. PubMed ID: 1924804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myocardial infarction after thrombolytic treatment of acute ischemic stroke.
    Santos N; Serrão M; Silva B; Pereira A; Faria P; Oliveira R; Caires G; Pereira D; Freitas D; Araújo J
    Rev Port Cardiol; 2009 Oct; 28(10):1161-6. PubMed ID: 20058780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. After thrombolytic therapy: avoiding a disabling complication.
    Cox CW
    Nursing; 1994 Jun; 24(6):32K-32L. PubMed ID: 8008273
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atheromatous material mobilization syndrome after thrombolytic therapy with streptokinase in acute myocardial infarct].
    Arpesani A; Beretta L; Giorgetti PL; Varesi C; Matturri L
    Minerva Cardioangiol; 1991 Jun; 39(6):251-4. PubMed ID: 1961445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The early risk of thrombolytic therapy for acute myocardial infarction: incidence, mechanisms and possible prevention.
    Verheugt FW
    J Cardiovasc Risk; 1998 Apr; 5(2):103-8. PubMed ID: 9821063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy for acute myocardial infarction in the 1990s.
    Effron MB; Morales RE
    Md Med J; 1991 Jun; 40(6):485-91. PubMed ID: 1830634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diffuse cholesterol embolism after fibrinolysis for myocardial infarction].
    Pochmalicki G; Meunier P; Feldman L; Rougeau JC; Chosidow O; Wechsler J; Jan F
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):263-6. PubMed ID: 8363430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.